India Cardiovascular Market Analysis Sample Report

India Cardiovascular
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of India Cardiovascular Market
and a forecast for its development in the medium and long term. It provides
a comprehensive overview of the market value, dynamics, segmentation,
characteristics, main players, trends and insights, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the India Cardiovascular Market, and offers
unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion

4 A Sample Report on Indian Cardiovascular Market I Confidential
Table of Contents
1. India Cardiovascular Market Overview………………....……..…………………………………................................................................07
1.2 Market size and forecast
2. India Cardiovascular Epidemiology….………………..……..…………………………………...................................................................09
2.1 Epidemiology Population - By Type
2.2 Epidemiology Population - By Mortality (Mn)
3. Market Growth Drivers ………………….…………………………………………………………………….………………………...………….12
3.1 Increase in diagnosis and treatment
3.2 Increase in prevalence of Cardiovascular Diseases
3.3 Technological advancements and low-cost medication
3.4 Increase in cardiac healthcare and domestic industries
4. Major Indication Contributing India Cardiovascular Market ….…..……………..……..…………………………………………..............18
4.1 Prevalence of different cardiovascular disease type
4.2 Unmet needs

Table of Contents (continued)
5. Market Segmentation………………………..…………………………………….……………………………………………...…………..…21
5.1 By Drug type
5.2 By Device type
5.3 By Distribution Channel
6. Competitive Landscape………………………………………………………………………………………………………………..…….....25
6.1 Competitive Landscape- Mergers And Acquisitions
6.2 Key Company By Revenue
6.3 Key Company By Sales
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials) ….………….………………….…....31
7.1 Abbott Laboratories
7.2 Boston Scientific Corporation
7.3 Medtronic Plc
7.4 Terumo Corporation
7.5 St. Jude Medical Inc
7.6 Edward Lifesciences Corporation
7.7 Vascular Concepts Limited
7.8 Cordis Corporation
7.9 Philips Healthcare
7.10 Biosense Webster, Inc

Table of Contents (continued)
8. Access and Reimbursement Scenario…………………………………………………………………….….…………….…………..…....52
8.1 Key Market Access Considerations
8.2 General reimbursement scenario
9. Factors Driving Future Growth…………………...………………………………….………………………………………………...……...54
9.1 Key Industry Developments
9.2 Cardiology Inventions
10. Conclusion………………………………………………………………………………………………………………………………….…....57

India Cardiovascular Market Analysis
1. Overview

1.1 India Cardiovascular Market- Market Size & Forecast Overview
The overall Cardiovascular market in India will experience sizable growth over the forecast period, increasing from $1.00 Bn in
2022 to over $1.79 Bn in 2030 with a CAGR of 7.52%
▪ India has one of the highest burdens of cardiovascular
disease (CVD and the annual number of deaths from CVD in
India is projected to rise from 2.26 Mn (1990) to 4.77 Mn
(2020)
▪ The market is growing rapidly due to improving quality and
operation standards, variation in the lifestyle and rising aging
population, attracting the investors
▪ Content
▪ Content
▪ Content
▪ Content
Key Findings

2. Epidemiology

2.1 Epidemiology Population - By Type
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Cardiovascular
Heart Disease
43 xx xx xx xx xx xx xx xx xx
Stroke 33 xx xx xx xx xx xx xx xx xx
Hypertensive
Heart Disease
5.4 xx xx xx xx xx xx xx xx xx
Rheumatic
Heart Disease
Prevalence of coronary heart disease in India (2019-2028), (%)
▪ Cardiovascular heart disease is likely to be more prevalent during the forecast period because of rising volume of
cardiovascular patients belonging to this type disease and is expected to maintain dominance during the forecast period
▪ Content
▪ Content
Key Highlights

2.2 Epidemiology Population - By Mortality (Mn)
▪ Cardiovascular heart disease is likely to be primary cause of mortality during the forecast period because of rising volume of
cardiovascular patients belonging to this type disease and is expected to maintain dominance during the forecast period
▪ Content
Key Highlights
Epidemiology Population - By proportional mortality in India due to cardiovascular diseases (2019-2028), (Mn)
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Cardiovascular
Heart Disease
Stroke 1.5 xx xx xx xx xx xx xx xx xx
Hypertensive
Heart Disease
Rheumatic
Heart Disease
1 xx xx xx xx xx xx xx xx xx

3. Growth Drivers and Growth Restraints

3.1 Market Growth Drivers
Technological advancements and
low-cost medication
Increase in cardiac healthcare and
domestic industries
Increase in diagnosis and treatment
Market Growth Drivers of India
Cardiovascular Market
Increase in prevalence of
cardiovascular diseases

3.1 Market Growth Drivers (continued)
3.1.1 Increase in cardiac healthcare and domestic industries
There are many cardiac healthcare and domestic industries focussing primarily on cardiovascular diseases viz.,
Kovai Medical Centre and Hospital in India provides continuum care for the prevention, treatment, recovery, and
rehabilitation of the heart and vascular diseases
The rise in cardiac healthcare and domestic industries have increased ‘Local innovation’ by MNCs as well as
domestic players and is expected to drive indigenous manufacturing of medical devices leading to rapid growth in
treatment facilities and exports
Sample

Market Growth Drivers (continued)
The sheer scale of the CVD in India has promoted the underused treatment resulting in decrease in large burden of
potentially avoidable mortality and morbidity, for example use of secondary prevention ACE inhibitors and statin has
increased from its original marginal use
Incidence of Congenital Heart Diseases (CHD) in children is a major threat in India. Affordability remains key
challenge, especially India being a country depending upon import for more than 80% drugs and patented drug
requirements. This is leading to rise in diagnosis and low-cost treatment
3.1.2 Increase in diagnosis and treatment
Sample

3.1.3 Increase in prevalence of cardiovascular diseases
Coronary heart disease prevalence rates in India have been estimated over the past several decades and have
ranged from 1.6% (1990) to 7.4% (2020) in rural populations and from 1% (1990) to 13.2% (2020) in urban
populations and thus driving the market of cardiovascular by creating awareness among individuals
The prevalence of cardiovascular diseases is increasing in India due to the shift in lifestyle and the other health
conditions responding to the change in the adoption of the modernized facilities and thus driving the market of
cardiovascular market
Sample
The increasing awareness and initiatives taken by regional governments are expected to propel the cardiovascular
devices market growth. Additionally, major investments are made to cater to the rising demand for cardiovascular
surgical devices, and this will help the market gain momentum in the forecast period

3.1.4 Technological advancements and low-cost medication
Cardiovascular devices in the Indian market are beneficial in technological advancements and low-cost medication to
cut down operational cost and is dominated by domestic manufacturers. These manufacturers are playing a vital role
in innovating new products to grow substantially as a medical giant to attract investors
The technological advancements are leading to increasing adoption of the pacemakers, and one of the recent
advancements include the development of a leadless pacemaker that is one-tenth the size of the predecessor
devices by Medtronic
Sample
The healthcare facilities and services in India is heading towards the technological advances. For instance, in India
Kim hospital provides services for the structural heart in the south Indian region

4. Major Indications Contributing
Cardiovascular Market

4.1 Major Indications- Prevalence Of Cardiovascular Disease Type
Market Share, By Disease Type (%), 2022 Key Highlights
▪ Cardiovascular heart disease is likely to dominate the
market during the forecast period because of rising
volume of cardiovascular patients belonging to this
type disease and is expected to maintain dominance
during the forecast period
▪ Content
▪ Content
▪ Content
▪ Content

4.2 Major Indications- Unmet Needs
▪ Cardiological clinical trials are more expensive as they
need longer follow-ups or a higher number of patients.
They are complicated and new, powerful, and
fundamental ideas to take cardiovascular (CV) diseases
seem to be lacking in India
▪ The continuous haemorrhaging of funding from
cardiology into other therapeutic areas due to ‘increased
cost of drugs’ is depriving CV medicine from adequate
support, and interest from public and industrial
institutions
▪ Content
▪ Content
▪ Content
▪ Content

5. Market Segmentation

5.1 Market Segmentation- By Drug Type
Market Share, By Drug Type (%), 2022
▪ The anticoagulants segments are estimated to hold a
dominant share in the global market, especially due to their
status as comparatively expensive drugs and the critical
life-preserving functions that they perform
▪ The other segments are some of the widely consumed
medications in India, but the presence of generic versions
of these medications have limited the growth potential
▪ Content
▪ Content
▪ Content
Key Highlights

5.2 Market Segmentation- By Device type
Market Share, By Device Type (%), 2022
▪ Interventional cardiology devices are dominant in market
due to increase in prevalent cases in India
▪ Heart rhythm problems (arrhythmias) have become
prevalent and are expected to further experience an
increase.
▪ According to the PAN Arrhythmia and Heart Failure
Registry (PANARM HF), in 2017, approximately 15% of
the total heart failure patients suffer from atrial fibrillation in
India
▪ The adoption rate of cardiac defibrillators and cardiac
resynchronization therapies are also expected to rise in
forecast period
▪ Content
Key Highlights

5.3 Market Segmentation- By Distribution Channel
▪ In 2022, hospitals held the largest market share of
approximately 50% of the cardiovascular devices
market and are also expected to be the fastest growing
segments of the market in 2030 owing to
advancements in the infrastructures of hospitals,
offering various services and facilities and others
▪ Others
Market Share, By Distribution Channel (%), 2022 Key Highlights

6. Competitive Landscape

Competitive Landscape
▪ The market for cardiovascular devices in India is
comprised of several global players along with the
local players. However, the number of local players
in the country is less and the market share is majorly
grabbed by global companies such as Abbott
Vascular, Boston Scientific, Medtronic, etc.
▪ Since India is a growing economy, more global
companies are expected to penetrate the market in
the coming future
▪ Content
▪ Content
▪ Content
Cardiovascular Market Size ($Bn) (2022-2030) Market Concentration
Consolidated- Market dominated by1-5 major players
Fragmented- Highly competitive market without
dominant players
Indian cardiovascular diseases market

6.1 Competitive Landscape- Mergers And Acquisitions
Acquisition
BMS successfully acquired Celgene in Nov 2019, after it gained regulatory approval from all
government authorities required, widening the company’s pipelines in oncology, haematology,
immunology and cardiovascular disease
In 2019, Microsoft partner with Apollo Hospitals as part of healthcare initiatives to combat
cardiovascular burden in India
Merger

Mergers And Acquisitions
Despite the stress on performance due to regulatory restrictions, the total value of M&A transactions in the hospital sector in
2019 recorded an increase of 155 percent amounting to ₹7,615 crore, the highest value in the sector in over five year, as
against transactions worth ₹2,991 crore done in 2018, according to rating agency ICRA
After witnessing years of healthy growth in revenues and profits till 2017, the sector, however, recorded diminishing returns in
2018 and 2019 due to pressure on margins, after a slew of regulatory actions, including caps on prices of oncology drugs,
cardiac stents and knee implants and the advent of the GST, leading to higher indirect tax burden and restrictions placed by the
governments of the National Capital
Content
Content

6.2 Competitive Landscape- Key Company By Revenue
Key Analysis
▪ As per the 2022 records, three companies are holding
the maximum cardiovascular devices market share,
namely Boston Scientific Corporation, Medtronic, and
Abbott
▪ High revenue generation from these companies is
attributable to the strong product portfolio, including heart
valves, advanced stents, and other cardiovascular
products
▪ Cardiovascular devices market manufacturers are
emphasizing on cardiopulmonary production, which will
further help to earn high revenues, especially from
previously untreatable patients
▪ Content
Market share of cardiovascular devices market in
financial year 2022, by leading company
Boston
Scientific
Corporation
Medtronic
Plc
Abbott
Laboratories
St. Jude
Medical Inc
Terumo
Corporation

6.3 Competitive Landscape- Key Company By Sales
Key Analysis
▪ JB Chemicals had the highest share of cardiac sales of
over 48 percent in the company across India in the
financial year 2022 and is expected to maintain
dominance during the forecast period. Ajanta Pharma
had the second-highest share of cardiac sales in the
country during the same time period followed by USV
▪ Based on key parameters such as the financial year of
2022, market coverage and sales indicate that, Sanofi
India, Macleods, Zydus, Intas, Dr. Reddy’s, Cipla, etc are
some other leading players in the cardiac market and are
likely to gain significant market share in the years to
come
▪ Content
Market share of cardiac sales in financial year 2022, by
leading company (%)
30.6
32.2
40.6
48.7
Alembic
IPCA
Sun
Lupin
Eris LS
Glenmark
Torrent
USV
Ajanta
JB Chemicals

7. Key Company Profiles

7.1 Abbott Laboratories
Company Name
Abbott Laboratories
Year of establishment
1888
Headquarter
Mumbai, India
Revenue
$34.6 Bn
Website
www.abbott.co.in
Company Overview
▪ Abbott Laboratories is a health care company specializing in
cardiovascular, diagnostics, diabetes and neuromodulation
products
▪ It primarily focuses on cardiac arrhythmias, coronary artery
disease, heart failure and heart valve disease among all
cardiovascular diseases
▪ Content

Abbott Laboratories (continued)
Sample
Breakdown of net revenue by segment, 2022
Revenues ($Bn), 2021-2030F
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.2 Boston Scientific Corporation
Company Name
Boston Scientific Corporation
Headquarter
Revenue
Website
Company Overview
Content

Boston Scientific Corporation (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.3 Medtronic Plc
Company Name
Medtronic Plc
Headquarter
Revenue
Website
Company Overview
Content

Medtronic Plc (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.4 Terumo Corporation
Company Name
Terumo Corporation
Headquarter
Revenue
Website
Company Overview
Content

Terumo Corporation (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.5 St. Jude Medical Inc
Company Name
St. Jude Medical Inc
Headquarter
Revenue
Website
Company Overview
Content

St. Jude Medical Inc (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.6 Edwards Lifesciences Corporation
Company Name
Edwards Lifesciences Corporation
Headquarter
Revenue
Website
Company Overview
Content

Edwards Lifesciences Corporation (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.7 Vascular Concepts Limited
Company Name
Vascular Concepts Limited
Headquarter
Revenue
Website
Company Overview
Content

Vascular Concepts Limited (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.8 Cordis Corporation
Company Name
Cordis Corporation
Headquarter
Revenue
Website
Company Overview
Content

Cordis Corporation (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.9 Philips Healthcare
Company Name
Philips Healthcare
Headquarter
Revenue
Website
Company Overview
Content

Philips Healthcare (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

7.10 Biosense Webster, Inc
Company Name
Biosense Webster, Inc
Headquarter
Revenue
Website
Company Overview
Content

Biosense Webster, Inc (continued)
Sample
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn

8. Access and Reimbursement Scenario

Access and Reimbursement Scenario
▪ Commercial insurance remains the largest and most lucrative system, providing healthcare coverage to millions of people
▪ Drug manufacturers often engage in complex pricing and formulary negotiations with numerous health plans offered by
manufacturers
▪ Public scrutiny on the high cost of branded medications in the India has grown, prompting some manufacturers to launch drugs at
below market prices
▪ Content
General Reimbursement Environment
Key Market Access Considerations
The physicians’ ability to prescribe brands is more
controlled, because of variety of generic versions
available in India
Despite the variety of generics available,
physicians encounter difficulties with
reimbursement as a downstream consequence of
individual variability in response to drugs
2
1

9 Factors Driving Future Growth

9.1 Key Industry Developments
On Oct 2020, Abbott launched CRT-Ds which is used to prevent sudden death similar to traditional ICDs, but in addition act to
restore the heart’s natural pattern of beating in patients with reduced cardiac function and progressive heart failure despite
optimal medical therapy
On Jan 2019, Medtronic launched a mobile app called MyCareLink Heart for linking a list of pacemakers to have a direct mode
of communication with the patient’s smartphone
On Jan 2019, India based Natco Pharma announced launch of valsartan-sacubril, a cardiovascular drug for the treatment of
congestive heart failure. Novartis AG holds the patent in India for valsartan-sacubitril called Vymada and went from Rs 90 lakh
in sales in March 2017, to Rs 123 crore in March 2020
Content

9.2 Cardiology Inventions
A team of Bhabha Atomic Research Centre has developed a compact pocket friendly ECG machine, priced around Rs. 4000.
The researchers claim that people will be able to afford one of these machines for their private use, just the way personal blood
sugar monitor or blood pressure monitor is used
Scientists at the Healthcare Technology Innovation Centre (HTIC), Chennai, invented a device to keep check on artery
stiffness and alerts in case of risk. The device is about the size of a digital television set top box has been tested in three
different clinical trials. All tests found the Indian machine to be on par with the commonly used imaging system
Content
Content

10. Conclusion

India’s cardiovascular market is growing rapidly due to improving
cardiac therapies and low cost medications that attract investors
▪ The market is growing rapidly due to improving quality and operation standards in the country, variation in the lifestyle and rising aging
population which is attracting the investors to invest across the country
▪ Cardiovascular drugs and devices in the Indian market are beneficial in technological advancements and low-cost medication which
are dominated by domestic manufacturers. These manufacturers are playing a vital role in the Indian market to grow it substantially as
a medical giant to attract investors. Innovation should progress from developing new products to gain an advantage over such
products more efficiently with new innovative techniques and business models
▪ There are other factors also which are boosting the market growth of the Indian market such as R&D, growing cardiac healthcare
units in the country and rise in domestic industries to compete with multinationals. Rising diagnostic centers across the globe,
investment from the government and private players have bolstered the market growth. Moreover, rising medical tourism and
increasing awareness among the society regarding the heart-related diseases are creating an opportunity for Indian cardiology market
to grow. India being on a preference list is the perfect destination for the healthcare services, especially for cardiac surgery
▪ Cardiac therapies have displaced anti-infectives to become India’s leading therapy within its pharmaceutical market. The Indian
cardiac market outperformed the Indian pharmaceutical market by 200 basis points. Basis point is a universal measurement system
where one basis point is equivalent to 1/100th of 1 percent. Hypertension drugs today form 65% of the cardiac market. Similarly,
combination drugs and patented molecules have grown more rapidly than the pharmaceutical market. Estimates based on key
parameters such as historical performance of the company, market coverage, capacity to build brands and portfolio management
indicate, that JB Chemicals, Ajanta and USV are among the leading players in the cardiac market and likely to gain significant market
share in the years to come

60 A Sample Report on Report Title I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and insightful
research
Reliable
The data is prepared by a
team of highly qualified &
experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to confidently
make smarter business and
strategic decisions
Real
Covers everything you
would need to know about
the market including
market size, competitive
analysis & much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

India Cardiovascular Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to India Cardiovascular Market Analysis Sample Report

Similar to India Cardiovascular Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

India Cardiovascular Market Analysis Sample Report